Clin2
NCT07034183Worth exploringRecruiting

First test of PRD001 in healthy volunteers

Healthy Volunteers

This first-in-human study tests a new drug called PRD001 in healthy volunteers. It's checking how safe the drug is and how the body handles it, with a focus on people of Japanese and Caucasian ancestry.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
86 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • Be a healthy man aged 18 to 45 (or up to 60 for some parts)
  • Have Japanese or Caucasian ancestry (for certain parts of the study)
  • No active tuberculosis, HIV, hepatitis B, or hepatitis C
  • For Part 2B: have mild high cholesterol or mild fatty liver
  • Be willing to follow the study schedule and procedures

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07522970Recruiting· Phase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Shanghai, Shanghai Municipality
NCT07271693Recruiting· Phase 1
Safety study of a new medicine in healthy volunteers

This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.

Christchurch
NCT06845839Recruiting· Phase 1
Testing a new drug in healthy volunteers

This trial tests a new drug called CAY001 in healthy volunteers to see how safe it is and how the body processes it. It may help researchers understand if the drug is safe enough to test in people with medical conditions later.

Fair Lawn, New Jersey
NCT06995820Recruiting· Phase 1
Safety study of AZD1613 in healthy volunteers

This is a first-in-human trial testing an experimental drug (AZD1613) in healthy volunteers. It helps doctors see if the drug is safe, how it is processed by the body, and how the immune system reacts. The trial is designed for healthy men and women who cannot become pregnant and may require participants to be of Chinese or Japanese descent for certain groups.

Glendale, California
NCT07745907Recruiting· Phase 1
A first-in-human study of a new drug in healthy Chinese and Japanese adults

This trial tests a single dose of an investigational drug called AMG 691 in healthy Chinese and Japanese volunteers to see how it is processed by the body and how safe it is. This is an early-phase study, so it may help make future treatments safer for people of similar backgrounds.

Las Vegas, Nevada
NCT07290283Recruiting· Phase 1
Testing safety of AZD3974 in healthy volunteers

This trial tests a new medicine called AZD3974 in healthy people to see if it is safe and how the body handles it. It may help find the right dose for future studies.

Glendale, California

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.